Jacqueline E Muller

Summary

Country: South Africa

Publications

  1. ncbi Depression and anxiety in multisomatoform disorder: prevalence and clinical predictors in primary care
    Jacqueline E Muller
    Medical Research Council Unit on Anxiety Disorders, Department of Psychiatry, Stellenbosch University, Tygerberg, W Cape
    S Afr Med J 98:473-6. 2008
  2. ncbi Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial
    Jacqueline E Muller
    Department of Psychiatry, Stellenbosch University, South Africa
    Int Clin Psychopharmacol 23:43-8. 2008
  3. ncbi Anxiety and medical disorders
    Jacqueline E Muller
    Medical Research Council Unit on Anxiety Disorders, Department of Psychiatry, Tygerberg, Cape Town 7505, South Africa
    Curr Psychiatry Rep 7:245-51. 2005
  4. ncbi Morphological features in a Xhosa schizophrenia population
    Liezl Koen
    Ngaphakathi Group, Department of Psychiatry, University of Stellenbosch, South Africa
    BMC Psychiatry 6:47. 2006
  5. ncbi Social anxiety disorder : current treatment recommendations
    Jacqueline E Muller
    Medical Research Council s Unit on Anxiety Disorders, Department of Psychiatry, University of Stellenbosch, Tygerberg, Cape Town, South Africa
    CNS Drugs 19:377-91. 2005
  6. ncbi Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study
    Soraya Seedat
    MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, PO Box 19063, Tygerberg 7505, Cape Town, South Africa
    Int Clin Psychopharmacol 18:279-84. 2003
  7. ncbi The social anxiety disorder spectrum
    Dan J Stein
    Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa
    J Clin Psychiatry 65:27-33; quiz 34-6. 2004
  8. ncbi Anxiety disorders and schizophrenia
    Jacqueline E Muller
    Medical Research Council Unit on Anxiety Disorders, Department of Psychiatry, University of Stellenbosch, PO Box 19063, Tygerberg, Cape Town 7505, South Africa
    Curr Psychiatry Rep 6:255-61. 2004
  9. ncbi Prevalence of obsessive compulsive disorder in first- and multi-episode male patients with schizophrenia-spectrum disorders
    Liezl Koen
    S Afr Med J 93:517-8. 2003
  10. ncbi Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]
    Paul D Carey
    MRC Research Unit on Anxiety Disorders, University of Stellenbosch, Cape Town, South Africa
    BMC Psychiatry 5:5. 2005

Detail Information

Publications11

  1. ncbi Depression and anxiety in multisomatoform disorder: prevalence and clinical predictors in primary care
    Jacqueline E Muller
    Medical Research Council Unit on Anxiety Disorders, Department of Psychiatry, Stellenbosch University, Tygerberg, W Cape
    S Afr Med J 98:473-6. 2008
    ..The aim of this study was to evaluate the prevalence of depressive and anxiety disorders in a South African sample MSD, and to compare demographic and clinical outcomes in those patients with and without co-morbidity...
  2. ncbi Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial
    Jacqueline E Muller
    Department of Psychiatry, Stellenbosch University, South Africa
    Int Clin Psychopharmacol 23:43-8. 2008
    ..Compared with placebo, escitalopram was associated with lower symptom scores, increased response and remission rates, and improved functioning...
  3. ncbi Anxiety and medical disorders
    Jacqueline E Muller
    Medical Research Council Unit on Anxiety Disorders, Department of Psychiatry, Tygerberg, Cape Town 7505, South Africa
    Curr Psychiatry Rep 7:245-51. 2005
    ..Such associations provide important clues for understanding the neurobiology of anxiety disorders...
  4. ncbi Morphological features in a Xhosa schizophrenia population
    Liezl Koen
    Ngaphakathi Group, Department of Psychiatry, University of Stellenbosch, South Africa
    BMC Psychiatry 6:47. 2006
    ....
  5. ncbi Social anxiety disorder : current treatment recommendations
    Jacqueline E Muller
    Medical Research Council s Unit on Anxiety Disorders, Department of Psychiatry, University of Stellenbosch, Tygerberg, Cape Town, South Africa
    CNS Drugs 19:377-91. 2005
    ..Over the past two decades, cognitive behavioural therapies for SAD have gained increasing empirical support. The optimal approach to the management of treatment-refractory SAD patients requires additional study...
  6. ncbi Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study
    Soraya Seedat
    MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, PO Box 19063, Tygerberg 7505, Cape Town, South Africa
    Int Clin Psychopharmacol 18:279-84. 2003
    ..These data also suggest an advantage for citalopram in treating comorbid depressive symptoms, although some patients may respond preferentially to an SSRI and other patients to an NRI...
  7. ncbi The social anxiety disorder spectrum
    Dan J Stein
    Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa
    J Clin Psychiatry 65:27-33; quiz 34-6. 2004
    ..Nevertheless, phenomenological and psychobiological data have led to the hypothesis that social anxiety symptoms and disorders lie on various dimensions...
  8. ncbi Anxiety disorders and schizophrenia
    Jacqueline E Muller
    Medical Research Council Unit on Anxiety Disorders, Department of Psychiatry, University of Stellenbosch, PO Box 19063, Tygerberg, Cape Town 7505, South Africa
    Curr Psychiatry Rep 6:255-61. 2004
    ..In the interim, however, the data emphasize the importance of assessing and treating comorbid anxiety symptoms and disorders in schizophrenia...
  9. ncbi Prevalence of obsessive compulsive disorder in first- and multi-episode male patients with schizophrenia-spectrum disorders
    Liezl Koen
    S Afr Med J 93:517-8. 2003
  10. ncbi Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]
    Paul D Carey
    MRC Research Unit on Anxiety Disorders, University of Stellenbosch, Cape Town, South Africa
    BMC Psychiatry 5:5. 2005
    ..Quetiapine is generally well tolerated and previous open-label data has produced mixed results in OCD and additional controlled data is needed...
  11. ncbi A case of "ifufunyane": a xhosa culture-bound syndrome
    Dana J H Niehaus
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
    J Psychiatr Pract 11:411-3. 2005